CAS: 56290-94-9 - Medroxalol
Formula:C20H24N2O5
InChI:InChI=1S/C20H24N2O5/c1-12(2-3-13-4-7-18-19(8-13)27-11-26-18)22-10-17(24)14-5-6-16(23)15(9-14)20(21)25/h4-9,12,17,22-24H,2-3,10-11H2,1H3,(H2,21,25)
InChI key:InChIKey=MPQWSYJGFLADEW-UHFFFAOYSA-N
SMILES:O=C(N)C1=CC(=CC=C1O)C(O)CNC(C)CCC2=CC=C3OCOC3=C2
- Synonyms:
- 260-099-3
- 5-(2-{[4-(1,3-Benzodioxol-5-Yl)Butan-2-Yl]Amino}-1-Hydroxyethyl)-2-Hydroxybenzamide
- 5-[2-[[3-(1,3-Benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]-2-hydroxybenzamide
- 56290-94-9
- Benzamide, 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]-2-hydroxy-
- Rmi 81968
- Medroxalol
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Medroxalol (Mixture of Diastereomers) REF: 4Z-M-205001CAS: 56290-94-9 | - - - | To inquire | Tue 07 Jan 25 | |
Medroxalol REF: TR-M203540CAS: 56290-94-9 | - - - | 5,339.00 € | Tue 18 Feb 25 | |
Medroxalol REF: TM-T61495CAS: 56290-94-9 | - - - | 1,834.00 €~2,940.00 € | Mon 24 Feb 25 | |
5-[2-[[3-(1,3-Benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide REF: 3D-FB171173CAS: 56290-94-9 | Min. 95% | - - - | Discontinued product |
Ref: 4Z-M-205001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Medroxalol
Controlled ProductCAS:56290-94-9
Formula:
C20H24N2O5
Color and Shape:
Neat
Molecular weight:
372.415
Ref: TR-M203540
1g | 5,339.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Medroxalol
CAS:56290-94-9
Medroxalol (RMI81968), an oral α- & β-adrenergic blocker, has antihypertensive and vasodilatory effects.
Formula:
C20H24N2O5
Color and Shape:
Liquid
Molecular weight:
372.42
Ref: TM-T61495
25mg | 1,834.00 € | ||
50mg | 2,940.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
5-[2-[[3-(1,3-Benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide
CAS:56290-94-9
5-[2-[[3-(1,3-Benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide is a drug used for the treatment of cardiac conditions. It has been shown …
Formula:
C20H25ClN2O5
Purity:
Min. 95%
Molecular weight:
408.88 g/mol
Ref: 3D-FB171173
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |